Presently, Chlorion is developing two small molecule leads for the treatment of neuropathic pain and epilepsy.
Learn MoreChlorion’s leadership is composed of top experts in the role of chloride homeostasis in pathology and drug discovery, in addition to seasoned biopharmaceutical executives.
Learn MoreDecember 2nd, 2009.
Public-Private Partnership Involving Chlorion on Short-List for Major Grant.